Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity | Zendy

James B. Yu | Zendy; Pamela R. Soulos | Zendy; Jeph Herrin | Zendy; Laura D. Cramer | Zendy; Arnold L. Potosky | Zendy; Kenneth B. Roberts | Zendy; Cary P. Gross | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity

Author(s) -

James B. Yu,

Pamela R. Soulos,

Jeph Herrin,

Laura D. Cramer,

Arnold L. Potosky,

Kenneth B. Roberts,

Cary P. Gross

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs463

Subject(s) - medicine , prostate cancer , radiation therapy , genitourinary system , odds ratio , confidence interval , toxicity , cancer , logistic regression , retrospective cohort study , oncology

Proton radiotherapy (PRT) is an emerging treatment for prostate cancer despite limited knowledge of clinical benefit or potential harms compared with other types of radiotherapy. We therefore compared patterns of PRT use, cost, and early toxicity among Medicare beneficiaries with prostate cancer with those of intensity-modulated radiotherapy (IMRT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research